March 28, 2017
Bayer Healthcare LLC hit generics manufacturer Apotex Corp. with a patent suit in Delaware federal court Tuesday for seeking U.S. Food and Drug Administration permission to make a generic version of the pharmaceutical giant's Stivarga cancer treatment.